Header Logo

Connection

Kelly Standifer to Receptors, Opioid, mu

This is a "connection" page, showing publications Kelly Standifer has written about Receptors, Opioid, mu.
Connection Strength

1.370
  1. Orphanin FQ/nociceptin potentiates [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin-Induced mu-opioid receptor phosphorylation. Mol Pharmacol. 2005 Aug; 68(2):447-56.
    View in: PubMed
    Score: 0.248
  2. Mu-opioid-induced desensitization of opioid receptor-like 1 and mu-opioid receptors: differential intracellular signaling determines receptor sensitivity. J Pharmacol Exp Ther. 2003 Sep; 306(3):965-72.
    View in: PubMed
    Score: 0.216
  3. Induction of G protein-coupled receptor kinases 2 and 3 contributes to the cross-talk between mu and ORL1 receptors following prolonged agonist exposure. Neuropharmacology. 2002 Nov; 43(6):979-90.
    View in: PubMed
    Score: 0.208
  4. Orphanin FQ/nociceptin-mediated desensitization of opioid receptor-like 1 receptor and mu opioid receptors involves protein kinase C: a molecular mechanism for heterologous cross-talk. J Pharmacol Exp Ther. 2002 Aug; 302(2):502-9.
    View in: PubMed
    Score: 0.205
  5. Biochemical and pharmacological characterization of mu, delta and kappa 3 opioid receptors expressed in BE(2)-C neuroblastoma cells. J Pharmacol Exp Ther. 1994 Sep; 270(3):1246-55.
    View in: PubMed
    Score: 0.118
  6. Modulation of Mu1 opioid binding by magnesium: evidence for multiple receptor conformations. J Pharmacol Exp Ther. 1993 Jul; 266(1):106-13.
    View in: PubMed
    Score: 0.109
  7. Assessing opioid regulation of adenylyl cyclase activity in intact cells. Methods Mol Med. 2003; 84:29-37.
    View in: PubMed
    Score: 0.053
  8. Orphanin FQ/nociceptin blocks chronic morphine-induced tyrosine hydroxylase upregulation. Brain Res Mol Brain Res. 2002 Sep 30; 105(1-2):38-46.
    View in: PubMed
    Score: 0.052
  9. beta-Funaltrexamine inactivates ORL1 receptors in BE(2)-C human neuroblastoma cells. Eur J Pharmacol. 2000 Aug 18; 402(1-2):R1-37.
    View in: PubMed
    Score: 0.045
  10. 3H-morphine-6beta-glucuronide binding in brain membranes and an MOR-1-transfected cell line. J Pharmacol Exp Ther. 1997 Sep; 282(3):1291-7.
    View in: PubMed
    Score: 0.036
  11. Differential blockade of morphine and morphine-6 beta-glucuronide analgesia by antisense oligodeoxynucleotides directed against MOR-1 and G-protein alpha subunits in rats. Neurosci Lett. 1995 Sep 29; 198(2):99-102.
    View in: PubMed
    Score: 0.032
  12. Affinity labeling of mu and kappa receptors with naloxone benzoylhydrazone. Mol Pharmacol. 1991 Mar; 39(3):290-8.
    View in: PubMed
    Score: 0.023
  13. TIPP[psi], a highly selective delta ligand. Neurosci Lett. 1994 Nov 07; 181(1-2):47-9.
    View in: PubMed
    Score: 0.007
  14. Gender effects and central opioid analgesia. Pain. 1991 Apr; 45(1):87-94.
    View in: PubMed
    Score: 0.006
  15. Reduction by central beta-funaltrexamine of food intake in rats under freely-feeding, deprivation and glucoprivic conditions. Brain Res. 1990 Dec 03; 535(1):101-9.
    View in: PubMed
    Score: 0.006
  16. Modulation of mu 1, mu 2, and delta opioid binding by divalent cations. Biochem Pharmacol. 1990 Jul 15; 40(2):382-4.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.